SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.230+0.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dalroi who wrote (266)2/28/2000 3:03:00 AM
From: Cheryl GaltRead Replies (1) of 557
 
Has anyone else listened to Parker's interview? It's upbeat.
vcall.com

She lists conferences where they'll be releasing trial data
- starting with AACR in April - Ph II head and neck
- ASCO in May
- Cystic fibrosis results at the American Society of Gene Therapy Conference, June 1-3

Made a strong statement about the QA of their gene therapy trials.

Asked about their burn rate / cash position, said:
- Our burn rate is pretty minimal, between our current collaborators and the current cash we have on hand.
- We have cash to get us well through into mid-2001
- We have a number of significant partnership discussions under way that would bring in cash
- If the equity markets continues to look exciting, we would certainly be looking at that as well.
.
.

Said: Expect to see a steady stream of trial data in the next 12-18 months.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext